GoodRx Holdings, Inc. — Director's Dealing 2021

Dec 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-12-01

Reporting Person: Bezdek Trevor (Director, Co-CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-01	Class A Common Stock	C	129375	$0.00	Acquired	260343	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-01	Restricted Stock Unit	$	M	256595	Disposed		Class B Common Stock (256595)	Direct
2021-12-01	Class B Common Stock	$	M	256595	Acquired		Class A Common Stock (256595)	Direct
2021-12-01	Class B Common Stock	$	F	127220	Disposed		Class A Common Stock (127220)	Direct
2021-12-01	Class B Common Stock	$	C	129375	Disposed		Class A Common Stock (129375)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Class B common stock.

F2: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020.

F3: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.